pindolol has been researched along with Chromosome Deletion in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Chromosome Deletion: Actual loss of portion of a chromosome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, RA | 2 |
| Sigal, IS | 2 |
| Candelore, MR | 2 |
| Register, RB | 1 |
| Scattergood, W | 1 |
| Rands, E | 1 |
| Strader, CD | 2 |
| Cheung, AH | 1 |
| Blake, AD | 1 |
2 other studies available for pindolol and Chromosome Deletion
| Article | Year |
|---|---|
Structural features required for ligand binding to the beta-adrenergic receptor.
Topics: Amino Acid Sequence; Animals; Binding, Competitive; Cell Line; Cell Membrane; Chromosome Deletion; C | 1987 |
Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Binding, Competitive; Chromosome Deletion; Cri | 1987 |